Haruhiro Inoue, Kazuki Yamamoto, Yuto Shimamura, Daisuke Azuma, Kei Ushikubo, Hiroki Okada, Yoshiaki Kimoto, Yohei Nishikawa, Ippei Tanaka, Mayo Tanabe, Manabu Onimaru, Marc Julius Navarro
OBJECTIVES: Anti-reflux mucosectomy (ARMS) and anti-reflux mucosal ablation (ARMA) were developed as interventions for proton pump inhibitor (PPI)-refractory/-dependent gastroesophageal reflux disease (GERD). Although ARMS and ARMA are established treatments for PPI-refractory GERD, reliance on natural healing for ulcer scar formation introduces uncertainty and bleeding risk. To address these issues, we introduced a novel approach called anti-reflux mucoplasty (ARM-P), which involves immediate closure of mucosal defects following mucosectomy...
October 29, 2023: Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society